Review whether connected-care records agree.
Remote Patient Monitoring is the first application. WardTrace gives a qualified reviewer a cited record of supplied-record disagreements and stated limits. It does not establish that care occurred.
The number that should worry every RPM vendor
In its 2024 audit of Medicare remote patient monitoring, the HHS Office of Inspector General found that about 43% of enrollees did not receive all three required components of RPM.Read the OIG report. That is not a fraud statistic. It is a completeness statistic, and completeness is relevant to the records an auditor may examine.
Records assembled only after a dispute may be harder to review and reconcile. The prototype is intended to organize supplied evidence earlier while leaving every payment, coverage, and legal decision to authorized people.
A small sample can create broader review work.
WardTrace is designed to preserve what was supplied and what the prototype found at review time. Its integrity receipt detects later changes to included content; it does not establish source authenticity, completeness, event occurrence, or admissibility.
Catch it before you bill
WardTrace reviews core eligibility, authorization, service, documentation, and clinical-review evidence against the claim. When supplied records disagree, it points a human reviewer to the sourced issue without publishing the detector recipe.
A flagged claim never becomes an automatic denial. It routes to your human review before it goes out the door. You decide what to file. You keep the bundle data.
Preserve records when no disagreement is detected
The prototype can preserve the same review structure for an encounter with no detected disagreement. That result means only that the enabled checks did not identify an issue in the supplied records. It is not a certification of accuracy, medical necessity, coverage, or honesty.
Reviewers remain responsible for the decision and for considering evidence outside the prototype's scope.
Commercial terms remain a hypothesis
Prototype-stage pricing has not been validated or finalized. Pilot scope, governance requirements, and reviewer workload must be measured before commercial terms are represented as established.
What a pilot looks like
We are at prototype stage, measured on a synthetic corpus. The first step with any vendor is a calibration pilot on your own data: we run the governed review, measure performance and workload on your claims, and report your results to you. We will not quote synthetic results as field performance, and you should not accept that from anyone.
Where Device Evidence can expand
RPM is the starting point, not the boundary. The same evidence layer can support DME, home diagnostics, infusion equipment, wearables, and other connected-care services where a device, service record, and claim must agree.